Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study.

MLA

Domany, Yoav, et al. “Repeated Oral Ketamine for Out-Patient Treatment of Resistant Depression: Randomised, Double-Blind, Placebo-Controlled, Proof-of-Concept Study.” The British Journal of Psychiatry : The Journal of Mental Science, vol. 214, no. 1, Jan. 2019, pp. 20–26. EBSCOhost, https://doi.org/10.1192/bjp.2018.196.

APA

Domany, Y., Bleich-Cohen, M., Tarrasch, R., Meidan, R., Litvak-Lazar, O., Stoppleman, N., Schreiber, S., Bloch, M., Hendler, T., & Sharon, H. (2019). Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study. The British Journal of Psychiatry : The Journal of Mental Science, 214(1), 20–26. https://doi.org/10.1192/bjp.2018.196

Chicago

Domany, Yoav, Maya Bleich-Cohen, Ricardo Tarrasch, Roi Meidan, Olga Litvak-Lazar, Nadav Stoppleman, Shaul Schreiber, Miki Bloch, Talma Hendler, and Haggai Sharon. 2019. “Repeated Oral Ketamine for Out-Patient Treatment of Resistant Depression: Randomised, Double-Blind, Placebo-Controlled, Proof-of-Concept Study.” The British Journal of Psychiatry : The Journal of Mental Science 214 (1): 20–26. doi:10.1192/bjp.2018.196.